Brought to you by 
Aurora, Hereditary Disease Foundation in Huntington's deal
04 Oct 2000
Executive Summary
Aurora Biosciences (drug discovery automation, software technology) has agreed to work with the Hereditary Disease Foundation, a nonprofit group researching various genetic and neurological disorders, to discover and develop Huntington's disease therapeutics.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aurora, Hereditary Disease Foundation in Huntington's deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice